Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, Jan. 18 '26)

Image
By G.M.

 


    BMJ

  1. MARTIN DS, Doidge JC, Gould D, Shahid T, et al
    The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study.
    BMJ. 2026;392:e085535.
    PubMed         Abstract available


    Int J Infect Dis

  2. AMODIO E, Aiello R, Battisti M, Casuccio A, et al
    Past Behavior Predicts Future Protection: Uncovering Key Drivers of Influenza Vaccine Acceptance in Italy in the Post-Pandemic Era.
    Int J Infect Dis. 2026 Jan 8:108379. doi: 10.1016/j.ijid.2026.108379.
    PubMed         Abstract available

  3. SEO G, Joo H, Song K, Kim M, et al
    Static and Dynamic Scoring Systems for Post-acute Sequelae of SARS-CoV-2 in a Korean Cohort.
    Int J Infect Dis. 2026 Jan 9:108378. doi: 10.1016/j.ijid.2026.108378.
    PubMed         Abstract available

  4. PIOVESAN C, Fabiani M, Pezzotti P, Ramigni M, et al
    Mortality for causes unrelated to COVID-19 by number of doses and by time since administration of COVID-19 vaccines: a retrospective cohort analysis in the Treviso province, Italy (2021-2025).
    Int J Infect Dis. 2026 Jan 11:108392. doi: 10.1016/j.ijid.2026.108392.
    PubMed         Abstract available

  5. ZHANG C, Zeng J, Yin L, Han W, et al
    Spatio-temporal dispersal patterns of SARS-CoV-2 in the Chinese mainland following the COVID-19 response adjustment.
    Int J Infect Dis. 2026 Jan 12:108391. doi: 10.1016/j.ijid.2026.108391.
    PubMed         Abstract available


    J Infect

  6. GEERS D, Aguilar-Bretones M, Zaeck LM, Gill PA, et al
    Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
    J Infect. 2026;92:106681.
    PubMed         Abstract available

  7. JABOYEDOFF M, Crisinel PA, Valtuille Z, Fafi I, et al
    Infection-related mortality in children in two European countries, 2015 - 2023: an interrupted time-series analysis.
    J Infect. 2026 Jan 9:106688. doi: 10.1016/j.jinf.2026.106688.
    PubMed         Abstract available

  8. BAIN V, Silva-Avelar I, Correa-Silva S, Matsuo OM, et al
    Immune profile of T-lymphocytes in pediatric patients recovered of COVID-19: A longitudinal report.
    J Infect. 2026 Jan 14:106691. doi: 10.1016/j.jinf.2026.106691.
    PubMed        


    J Med Virol

  9. MERROUCHE NEH, Aboudharam G, Thiol S, Terrer E, et al
    IgE Anti-Beta Coronaviruses Serology in Napoleon Soldiers, France.
    J Med Virol. 2026;98:e70800.
    PubMed         Abstract available

  10. YE J, Xu T, Xu C, Liu X, et al
    Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors.
    J Med Virol. 2026;98:e70801.
    PubMed         Abstract available

  11. SANCHEZ-GARCIA M, Tresguerres JAF, Alvarez-Gonzalez M, Hera B, et al
    Oral Melatonin in Critically Ill Patients With COVID-19: A Quasi-Experimental Pragmatic Trial.
    J Med Virol. 2026;98:e70807.
    PubMed         Abstract available

  12. PISIL Y, Shida H, Ruiz SM, Cho K, et al
    Structural Adaptability of IgA and IgM Supports Broad SARS-CoV-2 Variant Neutralization.
    J Med Virol. 2026;98:e70790.
    PubMed         Abstract available

  13. FRATTY IS, Kriger O, Weiss L, Vasserman R, et al
    Epidemiology of Enteroviruses Among Hospitalized Patients in Israel (2016-2024): CNS Involvement, Subtype Variability, and Seasonality.
    J Med Virol. 2026;98:e70810.
    PubMed         Abstract available


    J Virol

  14. ALVARADO RE, Lokugamage KG, Garvanska D, Estes LK, et al
    Key residues in SARS-CoV-2 NSP3 hypervariable region are necessary to modulate early stress granule activity.
    J Virol. 2026 Jan 14:e0200625. doi: 10.1128/jvi.02006.
    PubMed         Abstract available


    JAMA

  15. DILEK S, Rosen J, Levashkevich A, Sharfstein JM, et al
    The US Food and Drug Administration's Regulation of Mifepristone.
    JAMA. 2026 Jan 12. doi: 10.1001/jama.2025.23091.
    PubMed         Abstract available

  16. FATTAH M, Stoffel LA, Bubar KM, Bents SJ, et al
    Trends in County-Level Childhood Vaccination Exemptions in the US.
    JAMA. 2026 Jan 14:e2524407. doi: 10.1001/jama.2025.24407.
    PubMed        


    Lancet

  17. WHITAKER M, Elliott J, Gerard-Ursin I, Cooke GS, et al
    Profiling vaccine attitudes and subsequent uptake in 1.1 million people in England: a nationwide cohort study.
    Lancet. 2026 Jan 12:S0140-6736(25)01912-9. doi: 10.1016/S0140-6736(25)01912.
    PubMed         Abstract available


    Lancet Infect Dis

  18. KAKU Y, Fujiwara M, Uriu K, Yo MS, et al
    Humoral immunity after LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2.
    Lancet Infect Dis. 2026 Jan 12:S1473-3099(25)00772.
    PubMed        

  19. LEITNER DR, Walsh SR, Suzuki M, Desjardins M, et al
    Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.
    Lancet Infect Dis. 2026 Jan 7:S1473-3099(25)00682.
    PubMed         Abstract available


    N Engl J Med

  20. CAI M, Xie Y, Al-Aly Z
    2024-2025 Covid-19 Vaccine Outcomes in U.S. Veterans. Reply.
    N Engl J Med. 2026;394:307.
    PubMed        

  21. YANG C, Tebbutt SJ
    2024-2025 Covid-19 Vaccine Outcomes in U.S. Veterans.
    N Engl J Med. 2026;394:306-307.
    PubMed        

  22. LAMPERT R, Harmon KG
    Sudden Cardiac Arrest in Athletes.
    N Engl J Med. 2026;394:268-280.
    PubMed         Abstract available


    Nature

  23. ROZMAN B, Broennimann K, Rajan KS, Nachshon A, et al
    N(1)-Methylpseudouridine directly modulates translation dynamics.
    Nature. 2026 Jan 14. doi: 10.1038/s41586-025-09945.
    PubMed         Abstract available


    Science

  24. COHEN J
    Scientists reject call to retest childhood vaccines.
    Science. 2026;391:220-221.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »